Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,340 | -20,657 | -11,770 | -7,017 | 458 |
| Depreciation Amortization | 43 | 4,300 | 2,804 | 1,852 | 1,096 |
| Accounts receivable | 250 | -6,813 | -1,839 | 1,482 | 18 |
| Accounts payable and accrued liabilities | -2,653 | 9,531 | -2,440 | -2,265 | -5,554 |
| Other Working Capital | 5,231 | -5,090 | -9,708 | -6,169 | -6,082 |
| Other Operating Activity | -12,677 | -4,797 | 1,431 | -2,371 | 458 |
| Operating Cash Flow | $-3,466 | $-23,526 | $-21,522 | $-14,488 | $-9,606 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 3,358 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $3,358 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 5,815 | 5,110 | 2,790 | 2,841 |
| Common Stock Issued | N/A | 13,671 | 13,797 | 8,952 | 3,537 |
| Other Financing Activity | 0 | 0 | -591 | -591 | 0 |
| Financing Cash Flow | $N/A | $19,486 | $18,316 | $11,151 | $6,378 |
| Beginning Cash Position | 1,303 | 5,343 | 5,343 | 5,343 | 5,343 |
| End Cash Position | 1,195 | 1,303 | 2,137 | 2,006 | 2,115 |
| Net Cash Flow | $-108 | $-4,040 | $-3,206 | $-3,337 | $-3,228 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,466 | -23,526 | -21,522 | -14,488 | -9,606 |
| Free Cash Flow | -3,466 | -23,526 | -21,522 | -14,488 | -9,606 |